Graft Polymer (UK) PLC - London-based company focused on the development and production of polymer modification, biological supplements, and nano-drug delivery systems - Says completion and commissioning of new equipment plant in Slovenia is due around the end of July, and will ‘effectively double’ its production capacity. Says this will help it move towards being able to satisfy industry demand for modified polymers. Says it is aiming to accelerate growth using its ‘healthy’ commercial pipeline with output at the Slovenian plant expected to rise to 6,000 tonnes per year.

Chief Executive Officer Victor Bolduev says: ‘The commissioning of this pivotal plant is testament to the group’s increasing commercial momentum in a promising market with a continued strong outlook for this year. I am confident that it will play a major role in transforming our ability to win larger customer mandates and strengthen competitive positioning within the speciality chemicals sector, centred on our excellent innovation and specialist production capabilities.’

Current stock price: 2.68 pence, down 7.6% on Wednesday

12-month change: down 83%

Copyright 2023 Alliance News Ltd. All Rights Reserved.